Paths of Progress
Nurse Marie Zano and patient Madeline Gear begin another cancer treatment session together
Winter/Spring 2001
Volume 10, Number 1
Contents
Features
- Taming Tumors by Cutting Off Their Blood Supply
The theory that tumor growth depends on angiogenesis — new blood vessel development — is now widely accepted. Investigators believe angiogenesis inhibitors could be increasingly important in cancer treatment. - Research Provides Clues to Multiple Myeloma
Dana-Farber has an international reputation for developing innovative multiple myeloma treatments, thanks to the work of Kenneth Anderson, M.D., and his colleagues. - Oncology Nursing: Patient Care on the Front Lines
Nurses have been redefining their roles since the days of Florence Nightingale, but competence and compassion are still what inspire patient trust. - At the Forefront of Advances Against Breast Cancer
Early detection, prevention, and treatment are significantly reducing breast cancer mortality rates and helping women live better and longer. - A Conversation with Ted Kennedy Jr.
Diagnosed with cancer at age 12, Ted Kennedy Jr. survived, but lost a leg to the disease. Now a public interest attorney, Kennedy discusses his experiences at Dana-Farber and his life today.
Departments
- Dateline DFCI
The latest news, including an interview with new Institute President Edward J. Benz Jr., M.D. - Discoveries
Dana-Farber research updates - A Letter from the President
2000 Annual Report
Credits
President, Dana-Farber Cancer Institute Edward J. Benz Jr., M.D.
Chief of Staff Stephen E. Sallan, M.D.
Chair, Adult Oncology Lee M. Nadler, M.D.
Chair, Pediatric Oncology Stuart H. Orkin, M.D.
Chair, Executive Committee for Research Stanley J. Korsmeyer, M.D.
Chief of Communications Steven R. Singer
Director of Publications/Editor Paul Hennessy
Contributors Hilary F. Bennett, Robert Levy, Debra Ruder, Cindy Whitcome,
Saul Wisnia
Design John DiGianni
Production Assistance Steven Skelton
Photography C.J. Allen, Webb Chappell, Steve Gilbert, Shawn Henry, Bill
Horseman, Carol Lundeen, Mark Ostow, Kris Snibbe, Laura Wulf
Paths of Progress is published twice a year by Dana-Farber Cancer
Institute's Department of Communications. If you have any comments or
would like to be removed from the mailing list, contact:
Debra Ruder (debra_ruder@dfci.harvard.edu)
Editor, Paths of Progress
Dana-Farber Cancer Institute, Department of Communications
375 Longwood Ave., Boston, MA 02215-5347
(617) 632-4090
Copyright © 2003 Dana-Farber Cancer Institute. All rights reserved.
